Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rodrigo Burgos
Severe Dyslipidaemia After the Addition of Raltegravir to a Lopinavir/Ritonavir-Containing Regimen
Antiviral Therapy
Infectious Diseases
Pharmacology
Parasites of the Flatfish Paralichthys Adspersus (Steindachner, 1867) (Pleuronectiformes) From Northern Chile
Memorias do Instituto Oswaldo Cruz
Medicine
Microbiology
Related publications
Raltegravir Concentrations in the Genital Tract of HIV-1-Infected Women Treated With a Raltegravir-Containing Regimen (DIVA 01 Study)
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Lopinavir/Ritonavir in the Treatment of HIV-1 Infection: A Review
Therapeutics and Clinical Risk Management
Efficacy of a Nucleoside-Sparing Regimen of Darunavir/Ritonavir Plus Raltegravir in Treatment-Naive HIV-1-infected Patients (ACTG A5262)
AIDS
Infectious Diseases
Allergy
Immunology
Lopinavir/Ritonavir Population Pharmacokinetics in Neonates and Infants
British Journal of Clinical Pharmacology
Pharmacology
Lopinavir/Ritonavir Monotherapy After Virologic Failure of First-Line Antiretroviral Therapy in Resource-Limited Settings
AIDS
Infectious Diseases
Allergy
Immunology
An Observational Study in an Urban Ugandan Clinic Comparing Virological Outcomes of Patients Switched From First-Line Antiretroviral Regimens to Second-Line Regimens Containing Ritonavir-Boosted Atazanavir or Ritonavir-Boosted Lopinavir
BMC Infectious Diseases
Infectious Diseases
Lack of Effect From a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir-Ritonavir
Pharmacotherapy
Pharmacology
Cost-Effectiveness of Atazanavir/Ritonavir Against Lopinavir/Ritonavir in the Treatment of People Living With Hiv in Peru
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
HIV Patients' Gastrointestinal Tolerability and Treatment Satisfaction After Switching From Lopinavir/Ritonavir (LPV/r) SGC to Co-Formulated LPV/r Tablets
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health